Berberine Hydrochloride Attenuates Growth, Biofilm Formation, and Virulence Associated Phenotypes of Actinobacillus pleuropneumoniae Strain APP-2023
Current Microbiology · 2026
DOI: 10.1007/s00284-026-05129-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Kang Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science, Anhui Science and Technology University, Chuzhou, China. yankangedu@163.com. Hauptthemen laut MEDLINE: Actinobacillus pleuropneumoniae, Biofilms, Actinobacillus Infections, Anti-Bacterial Agents. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Talent Introduction Project of Anhui Science and Technology University, National Natural Science Foundation of China, Veterinary Science Peak Discipline Project of Anhui Science and Technology University.
Abstract (Originalsprache)
Actinobacillus pleuropneumoniae (A. pleuropneumoniae), the causative agent of porcine contagious pleuropneumonia, poses significant economic threats to the global swine industry, further compounded by increasing antimicrobial resistance. This study investigated the antibacterial and antivirulence effects of berberine hydrochloride (BBH) against A. pleuropneumoniae strain APP-2023 using in vitro assays and a murine infection model. BBH exhibited measurable antibacterial activity against the tested strain, with a minimum inhibitory concentration (MIC) of 312.5 µg/mL, indicating relatively modest growth-inhibitory potency. At subinhibitory concentrations, BBH reduced crystal violet-stained surface-associated biofilm biomass and increased bacterial susceptibility to oxidative and osmotic stress. Treated bacteria displayed marked morphological alterations including cell elongation, accompanied by reduced transcription of cell division genes ftsZ and ftsA. In the murine challenge model, infection with BBH-pretreated bacteria resulted in improved survival and reduced pulmonary bacterial burden. These findings provide preliminary evidence that BBH attenuates several virulence-associated phenotypes of A. pleuropneumoniae strain APP-2023 and warrant further mechanistic and translational studies in multiple strains and natural porcine infection models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Animal Science, Anhui Science and Technology University, Chuzhou, China. yankangedu@163.com.
- Anhui Province Key Laboratory of Animal Infectious Disease Prevention and Control, Chuzhou, China. yankangedu@163.com.
- Anhui Province Key Laboratory of Animal Nutrition Regulation and Health, Chuzhou, China. yankangedu@163.com.
- Anhui Engineering Technology Research Center of Pork Quality Control and Enhancement, Chuzhou, China. yankangedu@163.com.
- College of Animal Science, Anhui Science and Technology University, Chuzhou, China.
- Anhui Province Key Laboratory of Animal Infectious Disease Prevention and Control, Chuzhou, China.
Förderung
- Talent Introduction Project of Anhui Science and Technology University
- National Natural Science Foundation of China
- Veterinary Science Peak Discipline Project of Anhui Science and Technology University
Zitieren
APA
Yan, K., Chen, P., Wang, L., Zhu, C., Li, Y., Bei, W., & He, S. (2026). Berberine Hydrochloride Attenuates Growth, Biofilm Formation, and Virulence Associated Phenotypes of Actinobacillus pleuropneumoniae Strain APP-2023. Current Microbiology. https://doi.org/10.1007/s00284-026-05129-0
Vancouver
Yan K, Chen P, Wang L, Zhu C, Li Y, Bei W, et al. Berberine Hydrochloride Attenuates Growth, Biofilm Formation, and Virulence Associated Phenotypes of Actinobacillus pleuropneumoniae Strain APP-2023. Current Microbiology. 2026. doi:10.1007/s00284-026-05129-0
BibTeX
@article{Yan2026,
author = {Yan, Kang and Chen, Pengxu and Wang, Longhao and Zhu, Chengcai and Li, Yangyang and Bei, Weicheng and He, Shaojun},
title = {Berberine Hydrochloride Attenuates Growth, Biofilm Formation, and Virulence Associated Phenotypes of Actinobacillus pleuropneumoniae Strain APP-2023},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-05129-0}
}
EUVIMED